Rolf Fimmers

Medicine · Health Sciences

79h-index21.4kcitations474works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(42), Forensic and Genetic Research(29), Molecular Biology Techniques and Applications(26), Retinal Diseases and Treatments(20), Genetic Associations and Epidemiology(20)

Publications472 total

Stellungnahme der Spurenkommission zu Ringversuchen zum Zweck der Qualitätssicherung in forensisch-molekulargenetischen Laboratorien
Rechtsmedizin·2024· 1 citedOpen Access
Using cluster analysis for grouping partial autosomal haplotypes derived from single sperm STR profiling
Rechtsmedizin·2024· 4 citedOpen Access
Authors' response
Journal of Forensic Sciences·2023· 2 citedOpen Access
Synergy of Regenerative Periodontal Surgery and Orthodontics Improves Quality of Life of Patients with Stage IV Periodontitis: 24-Month Outcomes of a Multicenter RCT
Bioengineering·2023· 17 citedOpen Access
Effects of antioxidant supplementation on bone mineral density, bone mineral content and bone structure in healthy men during 60 days of 6° head‐down tilt bed rest: Results from a randomised controlled trial
Nutrition Bulletin·2023· 6 citedOpen Access
Supplementary Figure S6qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary Legends_qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary Figure S2qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary Figure S2qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Figure S1 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy
2023Open Access
Figure S1 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy
2023Open Access
Supplementary Figure S5qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Figure S2 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy
2023Open Access
Supplementary Figure S1qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary Figure S6qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary Tables S1qc-S3qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary Figures S3qc and S4qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary Tables S1qc-S3qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Figure S2 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy
2023Open Access
Supplemental Table 2 from Anticancer Effects of Niclosamide in Human Glioblastoma
2023Open Access
page 1 of 24Next →

Frequent Co-authors

Hans H. Schild(7), Otmar D. Wiestler(5), Johannes Schramm(5), Peter Albers(5), Uwe Schlegel(4), Daniel Thomas(4), Axel Heidenreich(4), Hojjat Ahmadzadehfar(4), Markus M. Nöthen(4), Ulrich Herrlinger(3), Michael Sabel(3), Matthias Simon(3), Horst Urbach(3), Martin Glas(3), Ingmar Blümcke(3), Ingo G.H. Schmidt‐Wolf(3), Thomas F. Wienker(3), Frank G. Holz(3), Roswitha Siener(3), S. Krege(3)